The Peptide Library · Longevity & the Supplement Aisle
The longevity supplement everyone is on, and the one honest question that decides whether it is worth it.
It reliably does the thing it promises to do inside your cells. Whether that thing actually makes you healthier or longer-lived is a completely separate question, and the honest answer is that nobody knows yet.
NAD+ rise: Conze 2019 (NR up to +142%), Christen 2026 (NMN and NR ~2x). Label analysis: ChromaDex 2021 (industry report). Sources at the end, PubMed-verified.
NAD+ is having its decade. It is in the morning stacks of every longevity influencer, sold as cellular fuel, a repair signal, and the closest thing we have to a recharge button for aging cells. The mechanism is genuinely one of the most fundamental in biology, and the marketing has run with it all the way to "reverse aging."
Here is the thing almost no ad tells you, and it is the whole story. Yes, these supplements really do raise your NAD+. That part is settled. What has never been shown in a single human trial is that raising it makes you age slower or live longer. This report holds those two facts side by side, so you can see exactly where the proof stops and the promise takes over.
Read this first
This is education, not medical advice, and not a recommendation to take or avoid anything. NAD+ precursors like NMN and NR are sold as dietary supplements; the anti-aging claims are not established. Doses mentioned are the ones studied, not a prescription. Product quality varies a great deal, so third-party testing matters. Talk to a provider, especially if you take medications or have a health condition. For research and educational purposes, adults 21 and over.
Why it is everywhere right now
Two things kept NAD+ in the feed this year. First, the most famous longevity self-experimenter of all publicly dialed his own NMN back, from daily to a few days a week, and dropped the one drug in his stack with the strongest longevity evidence over side effects. That sparked a healthy "wait, what is actually working here?" conversation in the community. Second, US regulators reversed an earlier decision and confirmed NMN can be sold as a supplement again, which reopened the market and the marketing at full volume.
So the noise is louder than ever, right as the most honest voices are getting more cautious. That gap is exactly where a calm read helps.
What it actually is
NAD+ is a coenzyme in every cell doing two jobs at once. It shuttles electrons in your mitochondria to make energy, the spark plug of the cellular engine, and it is the fuel burned by the repair-and-maintenance crew: sirtuins that manage stress and gene activity, and enzymes that fix DNA. As you age, cellular NAD+ falls, and that decline is linked to tired mitochondria and sloppier repair. The whole theory of these supplements is simple: top the battery back up, and maybe some of that decline slows.
You cannot just swallow NAD+ itself, it is too big to get into cells efficiently. So you take a smaller raw material, NMN or NR, that your body rebuilds into NAD+ inside the cell. Interestingly, recent human work suggests your gut bacteria are a required middle step in that conversion, which nobody expected.
The whole debate in one tool
Every argument about NAD+ comes down to one distinction: raising a lab number is not the same as improving your health. Tap a claim and see exactly where the human evidence stands.
Claim checker
The verdicts reflect human trial evidence as of mid-2026, not mechanism or animal data.
Notice the pattern as you move left to right: rock solid on the marker, mixed on the near-term functional stuff, and simply unproven on the big anti-aging promises. That gradient is the honest map of NAD+.
The evidence, sorted honestly
The one thing that is not in dispute is that these supplements raise NAD+. In a clean dose-response trial, nicotinamide riboside lifted whole-blood NAD+ steadily with dose.
Whole-blood NAD+ increase by NR dose
Percent rise over baseline after two weeks, dose-dependent and sustained (Conze 2019). This is the proven part.
Conze 2019, Sci Rep. NMN trials show a comparable reliable rise; the 2026 head-to-head found NMN and NR roughly doubled NAD+ (Christen 2026, Nat Metab).
Confirmed across many placebo-controlled human trials, dose-dependent and reproducible. If the goal is simply "make the number go up," it works.
One dose-response trial reported improved walking distance, but it was small and industry-funded. Blood-pressure and metabolic signals are weak, inconsistent, and largely unreplicated. Encouraging hints, not conclusions.
Zero human trials have shown it, and none have even been designed to. The lifespan data are from worms and mice, and that road is littered with compounds that never translated. Two major reviews call the human clinical benefit limited and inconsistent.
The honest one-liner
NMN and NR do exactly what they say to your NAD+ level, safely, in the short term. Whether that buys you a single healthier or longer day has not been shown in a person. Do not confuse the pharmacology working with your life getting better.
Safety, rules, and the bottle problem
The bottle you buy may not be the molecule you paid for
In one analysis of the top-selling NMN products, only a handful met their own label, most contained a tiny fraction of what they advertised, and some had no detectable NMN at all. Even if the science were settled, a mislabeled bottle would undo it. If you buy NMN, independent third-party testing is not optional, it is the whole game. (That analysis was industry-run, so read it as directional, but the pattern has held up in later testing.)
Both sides, fairly
Reasonable people land on different sides of this one. Here is the strongest fair version of each, and the part each side conveniently forgets.
One of the most fundamental molecules in biology, reliably restored, with a clean short-term record.
A decade of trials, and still not one convincing, replicated benefit in healthy people.
Cutting through the noise
Turn it into a clear decision
Not a push to take it. A way to decide with clear eyes.
Be honest about the goal. If you want a proven, raised NAD+ level, it delivers. If you want proven anti-aging, no supplement can honestly promise that yet.
Do the foundation first. Exercise, sleep, and not overeating are the best-proven ways to support NAD+ and healthy aging, by a wide margin.
If you buy, buy tested. Insist on independent third-party certification, because the label alone is unreliable.
Keep expectations calibrated to the evidence, not the ad. Promising is not proven, and short-term safe is not long-term known.
Loop in your provider if you take medications or have a condition, since long-term and interaction data are thin.
The BlessUp take
NAD+ deserves the attention it gets, just not the certainty. The biology is real, the decline with age is real, and the fact that a simple supplement can measurably restore the molecule is genuinely impressive. This is not a scam, and the mechanism is one of the most legitimate in the whole longevity aisle.
And after nearly a decade of human trials, the payoff that everyone is actually buying, aging slower, living longer, feeling better, has not been demonstrated in a single person. Both of those are true, and the honest position is to sit right in that tension. Be genuinely interested, keep your money and your hopes proportional to the evidence, buy tested product if you buy at all, and never let a rising lab number talk you out of the things that are actually proven to work: moving your body, sleeping well, and eating like you plan to be here a while. When the real outcome trials read out, we will update. Until then, hope is not data.
The evidence
Human trials and reviews, PubMed-verified. Several human trials are industry-funded, noted where relevant. Market-quality data is an industry report, flagged as directional.
Also referenced, not treated as clinical evidence: a 2021 industry market analysis of NMN product label accuracy (directional), the US FDA regulatory reversal reinstating NMN's supplement status (2025, public docket), and public statements by a prominent longevity self-experimenter. This report takes no position beyond what the cited evidence supports and does not recommend use.